Evaluating telehealth lifestyle therapy versus telehealth psychotherapy for reducing depression in adults with COVID-19 related distress: the curbing anxiety and depression using lifestyle medicine (CALM) randomised non-inferiority trial protocol.
Lauren M YoungSteve MoylanTayla JohnMegan TurnerRachelle OpieMeghan HockeyDean SaundersCourtney BruscellaFelice JackaMegan TeychenneSimon RosenbaumKhyati BankerSophie MahoneyMonica TemboJerry LaiNiamh MundellGrace McKeonMurat YucelJane SpeightPilvikki AbsetzVincent VersaceMary Lou ChattertonMichael BerkSam MangerMohammadreza MohebbiMark MorganAnna ChapmanCraig BennettMelissa O'SheaTetyana RocksSarah LeachAdrienne O'NeilPublished in: BMC psychiatry (2022)
Australia and New Zealand Clinical Trials Register (ANZCTR): ACTRN12621000387820 , Registered 8 April 2021.
Keyphrases
- clinical trial
- phase ii
- phase iii
- metabolic syndrome
- study protocol
- open label
- coronavirus disease
- weight loss
- physical activity
- cardiovascular disease
- sars cov
- double blind
- randomized controlled trial
- depressive symptoms
- sleep quality
- placebo controlled
- stem cells
- posttraumatic stress disorder
- respiratory syndrome coronavirus
- cell therapy
- borderline personality disorder
- drug induced